World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
64
Citations
16987
World Ranking
9548
National Ranking
726

Chemistry

D-Index
60
Citations
16160
World Ranking
9574
National Ranking
541

Oleg Fedorov publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Oleg Fedorov sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 287 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Oleg Fedorov D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Oleg Fedorov sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 64 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Oleg Fedorov is affiliated with the University of Oxford in the United Kingdom. Their research spans several main fields of study including Biochemistry, Genetics and Molecular Biology, Medicine, and Materials Science. These domains are further detailed into subfields such as Molecular Biology, Materials Chemistry, Infectious Diseases, Oncology, and Epidemiology.

The core scientific topics addressed by Fedorov encompass Peptidase Inhibition and Analysis, Crystallization and Solubility Studies, Ion-surface interactions and analysis, X-ray Diffraction in Crystallography, Lipid Membrane Structure and Behavior, Computational Drug Discovery Methods, and SARS-CoV-2 and COVID-19 Research.

Fedorov's publication record includes work in various reputable venues, with the most frequent being Zenodo (CERN European Organization for Nuclear Research), Science, Angewandte Chemie International Edition, BMC Infectious Diseases, and the Journal of Medicinal Chemistry.

  • Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors, 2023, Science
  • Binding-Site Purification of Actives (B-SPA) Enables Efficient Large-Scale Progression of Fragment Hits by Combining Multi-Step Array Synthesis With HT Crystallography, 2025, Angewandte Chemie International Edition
  • Antibiotic resistance and viral co-infection in children diagnosed with pneumonia caused by Mycoplasma pneumoniae admitted to Russian hospitals during October 2023-February 2024, 2025, BMC Infectious Diseases
  • Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor, 2024, Journal of Medicinal Chemistry
  • High-throughput crystallography for rapid early-stage fragment growth from crude arrays by low-cost robotics, 2023, Zenodo (CERN European Organization for Nuclear Research)

Frequent collaborators include L. Koekemoer, F. von Delft, James M. Bennett, T. Krojer, and Harold Grosjean, with multiple co-authored publications.

Best Publications

  • Selective inhibition of BET bromodomains.

    Panagis Filippakopoulos;Jun Qi;Sarah Picaud;Yao Shen

  • Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination.

    Masoud Vedadi;Frank H. Niesen;Abdellah Allali-Hassani;Oleg Y. Fedorov

  • RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.

    Sarah Picaud;Christopher Wells;Ildiko Felletar;Deborah Brotherton

  • A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

    Oleg Fedorov;Brian Marsden;Vanda Pogacic;Peter Rellos

  • Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

    Pietro Ciceri;Susanne Müller;Alison O'Mahony;Oleg Fedorov

  • The (un)targeted cancer kinome

    Oleg Fedorov;Susanne Müller;Stefan Knapp;Stefan Knapp

  • Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains

    Duncan A Hay;Oleg Fedorov;Sarah Martin;Dean C Singleton

  • Rapid covalent-probe discovery by electrophile fragment screening

    Efrat Resnick;Anthony Bradley;Jinrui Gan;Alice Douangamath

  • PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains

    Sarah Picaud;David Da Costa;Angeliki Thanasopoulou;Panagis Filippakopoulos

  • CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

    Ariane Hammitzsch;Cynthia Tallant;Oleg Fedorov;Alison O’Mahony

  • 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.

    David S. Hewings;Minghua Wang;Martin Philpott;Oleg Fedorov

  • Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.

    Sarah Picaud;Sarah Picaud;Oleg Fedorov;Oleg Fedorov;Angeliki Thanasopoulou;Katharina Leonards

  • Structural diversity in the RGS domain and its interaction with heterotrimeric G protein alpha-subunits.

    Meera Soundararajan;Francis S. Willard;Adam J. Kimple;Andrew P. Turnbull

  • Specific Clk Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing.

    Oleg Fedorov;Kilian Huber;Andreas Eisenreich;Panagis Filippakopoulos

  • Structural Analysis Identifies Imidazo[1,2-b]Pyridazines as PIM Kinase Inhibitors with In vitro Antileukemic Activity

    Vanda Pogacic;Alex N. Bullock;Oleg Fedorov;Panagis Filippakopoulos

  • Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

    Laetitia J. Martin;Manfred Koegl;Gerd Bader;Xiao-Ling Cockcroft

  • Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase

    Alex N. Bullock;Judit E. Debreczeni;Oleg Y. Fedorov;Adam Nelson

  • A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain

    Oakley B. Cox;Oakley B. Cox;Tobias Krojer;Patrick Collins;Octovia Monteiro;Octovia Monteiro

  • Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.

    Marion Schuller;Galen J. Correy;Stefan Gahbauer;Daren Fearon

  • LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor

    Peter G. K. Clark;Lucas C. C. Vieira;Cynthia Tallant;Oleg Fedorov

  • Kinase Inhibitor Selectivity Profiling Using Differential Scanning Fluorimetry

    Oleg Fedorov;Frank H. Niesen;Stefan Knapp

  • Abstract 5387: Dual kinase/bromodomain inhibitors for rationally designed polypharmacology

    Elizabeth R. Quinn;Pietro Ciceri;Susanne Müller-Knapp;Alison O'Mahony

Frequent Co-Authors

Stefan Knapp
Stefan Knapp Goethe University Frankfurt
Cheryl H. Arrowsmith
Cheryl H. Arrowsmith Structural Genomics Consortium
Aled M. Edwards
Aled M. Edwards Structural Genomics Consortium
Panagis Filippakopoulos
Panagis Filippakopoulos Structural Genomics Consortium
Paul Brennan
Paul Brennan International Agency For Research On Cancer
Susanne Müller
Susanne Müller Structural Genomics Consortium
Alex N. Bullock
Alex N. Bullock University of Oxford
Opher Gileadi
Opher Gileadi Karolinska Institute
Udo Oppermann
Udo Oppermann University of Oxford
Masoud Vedadi
Masoud Vedadi Structural Genomics Consortium

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Chemistry in the USA opens doors to a variety of related online degrees and career paths that complement the core discipline. For those interested in the legal side of science, pursuing an online associates in criminal justice can provide foundational knowledge helpful in forensic chemistry roles.

Understanding the cost of criminal justice degree programs is vital when planning your education, as budgeting for tuition and fees will impact your long-term academic strategy.

Similarly, degrees like the paralegal associate degree can provide entry points into regulatory and compliance roles within pharmaceutical companies or chemical manufacturing firms.

For those aiming to blend chemistry knowledge with business skills, becoming a pharmaceutical sales representative is a lucrative option. Reviewing the drug rep salary and career pathways can give practical insight into this industry.

Overall, linking chemistry with these complementary degrees can broaden career opportunities and enhance the value of your scientific expertise.

Best Scientists Citing Oleg Fedorov

Trending Scientists

Recently Published Articles